By Deena Beasley Feb 10 (Reuters) – Gilead Sciences on Tuesday issued a 2026 financial forecast that was at the low end of analysts’ expectations and its shares fell nearly 6%. The California-based …
Gilead 2026 outlooks short of Wall Street view, shares fall
view original post